Autoimmune Phenomena in Non-Hodgkin's Lymphoma

References

• Miller D.G. The association of immune disease and malignant lymphoma. Ann. Int. Med. 1967; 66: 507–521
   PubMed Web of Science ®Google Scholar
• Jones S.E. Autoimmune disorders and malignant lymphoma. Cancer 1973; 31: 1092–1098
   PubMed Web of Science ®Google Scholar
• Dührsen U., Augener W., Zwingers T., Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br. J. Haematol. 1987; 67: 235–239
   PubMed Web of Science ®Google Scholar
• d'Amore F., Christensen B.E., Thorling K., et al. incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registry. Leukemia Lymph. 1993; 12: 69–77
   PubMed Web of Science ®Google Scholar
• Lennert K. Malignant lymphomas other than Hodgkin's Disease. Springer, Berlin 1978
   Google Scholar
• National Cancer Institute., Sponsored study of classifications of non-Hodgkin's lymphomas. 1982 Summary and description of a working formulation for clinical usage. Cancer, 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Krüger G.R.F., Medina J.R., Klein H.O., Konrads A., Zach J., Rister M., Janik G., Evers K.G., Hirano T., Kitamura H., Bedoy a V.A. A new working formulation of non-Hodgkin' s lymphomas. Cancer 1983; 52: 833–840
   PubMed Web of Science ®Google Scholar
• George J.N. Platelet IgG: measurement, interpretation and clinical significance. Progress in Hemostasis and Thrombosis, B.S. Coller. W. B. Saunders Company, Philadelphia 1991; 97–126
   Google Scholar
• Tarone R.E., Ware J. on distribution-free tests for equality of survival distributions. Biometrika 1977; 64: 156–160
   Web of Science ®Google Scholar
• Cox D.R. Regression models and life tables. J. Royal Statistical Soc. 1972; 34: 187–220
   Google Scholar
• Sela O., Shoenfeld Y. Cancer in autoimmune diseases. Seminars in Arthritis and Rheumatism 1988; 18: 77–87
   PubMed Web of Science ®Google Scholar
• Symmons D.P.M. Neoplasia in rheumatoid arthritis. J. Rheumatol. 1988; 15: 1319–1322
   PubMed Web of Science ®Google Scholar
• Lawrence J.S. Rheumatism in Populations. William Heineman Medical Books, Ltd., London 1977; 202–210
   Google Scholar
• Merl S.A., Theodorakis M.E., Goldberg J., Gottlieb A.J. Splenectomy for thrombocytopenia in chronic lymphocytic leukemia. Am. J. Hematol. 1983; 15: 253–259
   PubMed Web of Science ®Google Scholar
• Rudders R.A., Aisenberg A.C., Schiller A.L. Hodgkin's disease presenting as “idiopathic” thrombocytopenic purpura. Cancer 1972; 30: 220–230
   PubMed Web of Science ®Google Scholar
• Merlini G., Farhangi M., Osserman E.F. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Sem. Oncol. 1986; 13: 350–365
   PubMed Web of Science ®Google Scholar
• Homing S.J., Weiss L.M., Crabtree G.S., Warnke R.A. Clinical and phenotypic diversity of T cell lymphomas. Blood 1986; 67: 1578–1582
   PubMed Web of Science ®Google Scholar
• Coiffier B., Berger F., Bryon P.A., Magaud J.P. T-cell lymphomas: immunologic. histologic, clinical, and therapeutic analysis of 63 cases. J. Clin. Oncol. 1988; 6: 1584–1589
   PubMed Web of Science ®Google Scholar
• Armitage J.O., Greer J.P., Levine A.M., Weisenburger D.D., Formenti S.C., Bast M., Conley S., Pierson J., Linder J., Cousar J.B., Nathwani B.N. Peripheral T-cell lymphoma. Cancer 1989; 63: 158–163
   PubMed Web of Science ®Google Scholar
• Knecht H. Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge. Sem. Hematol. 1989; 26: 208–215
   PubMed Web of Science ®Google Scholar
• Feller A.C., Griesser H., Schilling C.V., Wacker H.H., Dallenbach F., Bartels H., Kuse R., Mak T.W., Lennert K. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am. J. Pathol. 1988; 133: 549–556
   PubMed Web of Science ®Google Scholar
• Frizzera G., Moran E.M., Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am. J. Med. 1975; 59: 803–818
   PubMed Web of Science ®Google Scholar
• Pangalis G.A., Moran E.M., Rappaport H. Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood 1978; 51: 71–83
   PubMed Web of Science ®Google Scholar
• Ganesan T.S., Dhaliwal H.S., Dorreen M.S., Stansfeld A.G., Habeshaw J.A., Lister T.A. Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study. Br. J. Cancer 1987; 55: 437–442
   PubMed Web of Science ®Google Scholar
• Knowles D.M., Halper J.P. Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases. Am. J. Pathol. 1982; 106: 187–203
   PubMed Web of Science ®Google Scholar
• Weis J.W., Winter M.W., Phyliky R.L., Banks P.M. Peripheral T-cell lymphomas: histologic, immunohistologic, and clinical characterization. Mayo Clinic Proceedings 1986; 61: 411–426
   PubMed Web of Science ®Google Scholar
• Pinkus G.S., O'Hara C.J., Said J.W. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease. Clinical, pathologic, and immunologic features of 78 cases. Cancer 1990; 65: 971–998
   PubMed Web of Science ®Google Scholar
• Youinou P., Mackenzie L.E., Lamour A., Mageed R.A., Lydyard P.M. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur. J. Clin. Invest. 1993; 23: 139–150
   PubMed Web of Science ®Google Scholar
• Casali P., Notkins A.B. CD5 + B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today 1989; 10: 364–368
   PubMedGoogle Scholar
• Raveche E.S. Possible immunoregulatory role for CD5 + B cells. Clin. Immunol. Immunopathol. 1990; 56: 135–150
   PubMedGoogle Scholar
• Bataille R., Klein B. CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis. Anticancer Res. 1988; 8: 707–710
   PubMed Web of Science ®Google Scholar
• Kipps T.J., Robins B.A., Tefferi A., Meisenholder G., Banks P.M., Carson D.A. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. Am. J. Pathol. 1990; 136: 809–816
   PubMed Web of Science ®Google Scholar
• Raffeld M., Jaffe E.S. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78: 259–263
   PubMed Web of Science ®Google Scholar
• Hamblin T.J., Oscier D.G., Young B.J. Autoimmunity in chronic lymphocytic leukaemia. J. Clin. Pathol. 1986; 39: 713–716
   PubMed Web of Science ®Google Scholar
• Dighiero G. Biology of the neoplastic lymphocyte in B-CLL. Clin. Haematol. 1993; 6: 807–820
   Google Scholar
• Michaeli J., Lugassy G., Raz I., Polliack A. Chronic lymphocytic leukemia, lymphoma and autoimmunity. Chronic lymphocytic leukemia, A. Polliack, D. Catovsky. Harwood Academic Pub., ReadingUK 1988; 231–247
   Google Scholar
• Gale R.P., Foon K.A. Biology of chronic lymphocytic leukemia. Chronic lymphocytic leukemia, A. Polliack, D. Catovsky. Harwood Academic Pub., ReadingUK 1988; 263–287
   Google Scholar